Immunotherapy
Utilizing Immunotherapy to Treat Late-Stage Cancers
Introduction Immunotherapy has become a groundbreaking method in cancer treatment, especially for advanced-stage cancer treatments that have demonstrated minimal effectiveness with standard medicines. This innovative appr..
CAR T-Cell, CAR therapy, Immunotherapy, T cell therapy
Is CAR T-Cell Therapy Available In India?
Have you ever wondered if there is a powerful way to fight cancer? Now just imagine if one day you found a ray of hope in your fight against cancer, a treatment that uses the power of your body's own immune system to target an..
2seventy bio, China, Immunotherapy, JW Therapeutics, Partnership
JW Therapeutics and 2seventy bio Announce Strategic Partnership to Accelerate the Research and Development of T-cell-based Immunotherapies
SHANGHAI, CHINA and CAMBRIDGE, MASSACHUSETTS, US, October 27, 2022 - JW Therapeutics (HKEX: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing, and commercializing cell immunotherap..
BMS, Bristol Myers Squibb, Immunotherapy, metastatic melanoma, nivolumab and relatlimab, nivolumab and relatlimab-rmbw, Opdualag, USFDA
First LAG-3-Blocking antibody combination, Opdualag™ (nivolumab and relatlimab-rmbw), is approved by FDA for patients with unresectable or metastatic melanoma
April 2022: The US Food and Drug Administration (FDA) has approved Opdualag (nivolumab and relatlimab-rmbw), a new, first-in-class fixed-dose combination of nivolumab and relatlimab administered as a single intravenous infusion, f..
High tumor burden, Immunotherapy, KEYTRUDA, Pembrolizumab, TMB-H
Pembrolizumab approved for use in any cancer with a high tumor mutational burden
July 2021: The US Food and Medication Administration (FDA) has expanded the indications for pembrolizumab (Keytruda), an immunotherapy drug, to encompass any cancer with a high mutational burden (TMB-H). The new authorization is f..
Immunotherapy, Liver, Singapore, Treatment
Singapore first approved T cell engineering immunotherapy for liver cancer
August 19, 2018: Singapore biotechnology company Lion TCR Pte. Ltd. was approved by the Singapore Health Sciences Authority (HSA), and its candidate product (LioCyx ™) can be used for phase I / II clinical research for the treat..
CAR NK, Immunotherapy
CAR natural killer cell therapy – MD Anderson partners with Takeda
The University of Texas MD Anderson Cancer Center and Takeda Pharmaceutical Company Limited have entered a restrictive understanding and research consent to develop and market chimeric antigen receptor directed natural killer (CAR..
Immunotherapy, Natural killer therapy, NK Cell therapy
CAR-NK therapy – New immunotherapy in cancer treatment
CAR-NK therapy is a new type of immunotherapy in the treatment of cancer treatment. Immunotherapy has revolutionized the way cancer is treated. Cancer immunotherapy is divided into two categories: one is immune checkpoint inhibit..
Drugs, Immunotherapy
New immunotherapy drug in cancer
Immune checkpoint inhibitors are a class of drugs that fight with the immune system of the body to fight cancerous cells. However, most patients do not respond to these therapies. There is a newer class of drug that targets two pr..